Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with increasing
prevalence over the past decades. 1, 2 Patients with AF increased risk for hospitalization …

Atrial fibrillation (AF) is the most common type of arrhythmia. With an aging world population
and changing lifestyles, the frequency of this arrhythmia is rapidly increasing. The main …

Patients with atrial fibrillation (AF) should receive anticoagulation with warfarin or direct oral
anticoagulants (DOACs) if the CHA 2 DS 2-VASc (Congestive heart failure, Hypertension …

Menichelli, D., Del Sole, F., Di Rocco, A., Farcomeni, A., Vestri, A., Violi, F. et al. Real-world
safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and …

Atrial fibrillation (AF) is the most common cardiac rhythm disorder (1) and can result in
negative cardiovascular outcomes such as stroke and mortality, especially in patients with …

Background The management of non-valvular atrial fibrillation (AF) has evolved with the
development of direct oral anticoagulants (DOACs). However, data regarding the …

Atrial fibrillation (AF) is the most common arrhythmia worldwide, increasing in incidence with
the aging population. Substantial morbidity and mortality accompany its diagnosis …

Anticoagulation therapy (AT) is the cornerstone of atrial fibrillation (AF) treatment for
thromboembolic event prevention. The AF burden, however, is of predictive relevance and …

Atrial fibrillation (AF) currently affects nearly 2% of the general adult population, and its
prevalence is rising (1, 2). Compared with individuals in sinus rhythm, AF patients have …

Background Oral anticoagulation is recommended as a lifelong therapy for most patients
with atrial fibrillation (AF). However, data on long-term outcomes in clinical practice on these …